Characteristics of patients with type 2 diabetes mellitus newly treated with GLP-1 receptor agonists (CHADIG Study): a cross-sectional multicentre study in Spain

OBJECTIVE: Several glucagon-like peptide-1 (GLP-1) receptor agonists (GLP-1Ra) have been made recently available in Spain for type 2 diabetes mellitus (DM2) treatment. There are no published data on the clinical and sociodemographic profile of patients initiating treatment with GLP-1Ra in Spain. Our...

Descripción completa

Detalles Bibliográficos
Autores principales: Conget, Ignacio, Mauricio, Dídac, Ortega, Rafael, Detournay, Bruno
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2016
Materias:
Diabetes and Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4964200/
https://www.ncbi.nlm.nih.gov/pubmed/27466235
http://dx.doi.org/10.1136/bmjopen-2015-010197

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4964200/
https://www.ncbi.nlm.nih.gov/pubmed/27466235
http://dx.doi.org/10.1136/bmjopen-2015-010197

Ejemplares similares